← back to search

Stefano Panareo

University of Ferrara · IT
🔎 Find collaborators in Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine
Research interest
Research focused on Positron emission tomography and Breast cancer, with related work in Radionuclide therapy, Neuroendocrine tumors, Radiomics. Notable publications include 'PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review', 'Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives', and '90Y/177Lu-DOTATOC: From Preclinical Studies to Application in Humans'.
h-index
citations
500
works
42
NIH funding
primary concept
email

Recent publications

Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study
Radiology Imaging Cancer 2025cited by 3position: middledoi
Real-world, multicenter assessment of 18 F-FDG PET/CT prognostic value in triple-negative breast cancer (TRINE-PET): the study protocol
Clinical and Translational Imaging 2025cited by 1position: middledoi
Real-World, Multicenter Assessment of 18F-FDG PET/CT Prognostic Value in Triple-Negative Breast Cancer (TRINE-PET): the Study Protocol
Research Square 2025cited by 0position: middledoi
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)
Journal of Nuclear Medicine 2024cited by 22position: middledoi
A Prospective Randomized Multicenter Study on the Impact of [<sup>18</sup>F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer
Journal of Nuclear Medicine 2024cited by 5position: middledoi
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study
Clinical and Translational Imaging 2024cited by 1position: middledoi
Extramedullary disease in multiple myeloma: what you might not expect on [18F]FDG PET/CT - a pictorial essay
Clinical and Translational Imaging 2024cited by 0position: middledoi
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?
Journal of Clinical Medicine 2023cited by 14position: middledoi
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors
Cancers 2023cited by 13position: middledoi
Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis
Diagnostics 2023cited by 12position: middledoi
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review
Cancers 2023cited by 11position: middledoi
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake
Expert Review of Medical Devices 2023cited by 7position: middledoi
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art
Journal of Clinical Medicine 2023cited by 6position: lastdoi
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT
Diagnostics 2023cited by 5position: middledoi
Can Baseline [ <sup>18</sup> F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study
Cancer Biotherapy and Radiopharmaceuticals 2023cited by 1position: middledoi
Lymphoid Organs’ Metabolism and its Role in Predicting the Outcomes of Patients with Malignant Melanoma Treated with Immunotherapy – an Exploratory Study
Research Square 2023cited by 0position: middledoi
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review
International Journal of Molecular Sciences 2022cited by 64position: lastdoi
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives
Journal of Cancer Research and Clinical Oncology 2022cited by 50position: middledoi
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial
Pharmaceutics 2022cited by 24position: middledoi
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer
Cancers 2022cited by 21position: middledoi
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review
Endocrine 2022cited by 12position: middledoi
Il linfonodo sentinella nel carcinoma differenziato della tiroide
L Endocrinologo 2022cited by 1position: lastdoi
La paratiroidectomia radioguidata: quando e come
L Endocrinologo 2022cited by 0position: lastdoi
Ita-immuno-pet: the Role of Fdg Pet/ct for Assessing Response to Immunotherapy
Research Square 2022cited by 0position: middledoi
Incidental Findings of Acute Myeloid Leukemia in Sjögren's Syndrome Detected by Nuclear Medicine Techniques
Indian Journal of Nuclear Medicine 2022cited by 0position: middledoi
90Y/177Lu-DOTATOC: From Preclinical Studies to Application in Humans
Pharmaceutics 2021cited by 46position: middledoi
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study
European Journal of Nuclear Medicine and Molecular Imaging 2021cited by 27position: middledoi
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer
The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021cited by 5position: middledoi
Efficacy of Lutetium-Peptide Receptor Radionuclide Therapy in Inducing Prolonged Tumour Regression in Small-Bowel Neuroendocrine Tumours: A Case of Favourable Response to Retreatment after Initial Objective Response
Oncology Research and Treatment 2021cited by 3position: middledoi
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report
Diagnostics 2020cited by 7position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Luca Urso · University of Ferrara24 papers (2020–2025)Mirco Bartolomei · Arcispedale Sant'Anna20 papers (2018–2024)Corrado Cittanti · University of Ferrara15 papers (2013–2023)Laura Evangelista · University of Padua13 papers (2017–2025)Angelo Castello · University of Ferrara10 papers (2022–2023)Ilaria Rambaldi · University of Ferrara8 papers (2017–2023)Alberto Nieri · University of Ferrara7 papers (2021–2023) · 7 papers (2022–2023)Licia Uccelli · Union des Industries Ferroviaires Européennes7 papers (2018–2023) · 6 papers (2021–2025) · 6 papers (2023–2025)Fabio Zattoni · University of Padua5 papers (2017–2024)Ivan Santi · University of Ferrara5 papers (2013–2020)Matteo Caracciolo · University of Ferrara5 papers (2021–2023) · 5 papers (2022–2023)Luciano Feggi · University of Ferrara4 papers (2013–2015)Maria Chiara Zatelli · University of Padua4 papers (2014–2022) · 3 papers (2017–2019)Natale Quartuccio · University of Ferrara3 papers (2020–2022) · 3 papers (2017–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Radiology, Nuclear Medicine and Imaging · Pulmonary and Respiratory Medicine →